Skip to content

Efficacy and Safety Study of Total Flavonoids of Propolis Dropping Pill to Treat Angina Pectoris

Phase III Study of Total Flavonoids of Propolis Dropping Pill in Angina Pectoris: A Randomized, Double-Blind, Placebo-Controlled Multi-Centered Clinical Trial on Efficacy and Safety.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01453582
Enrollment
478
Registered
2011-10-18
Start date
2011-12-31
Completion date
2015-09-30
Last updated
2018-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stable Angina Pectoris

Keywords

Chest stuffiness of TCM, Qi deficiency and blood stasis of TCM

Brief summary

The purpose of this study is to confirm the efficacy and safety of total flavonoids of propolis dropping pill to treat angina pectoris, evaluated by total exercise time of treadmill exercise test.

Interventions

DRUGTotal Flavonoids of Propolis dropping pill

One pack contains 30 pills, weight 33g. One pack each time, three times a day, 14 days a course.

DRUGtotal Flavonoids of Propolis dropping pill

One pack contains 30 pills, weight 33g. One pack each time, three times a day, 14 days a course.

Sponsors

Shanghai Greenvalley Pharmaceutical Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
35 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Class I, Class II and Class III stable angina pectoris, angina attack more than 3 times one week; * Qi deficiency and blood stasis syndrome of Traditional Chinese Medicine; * In resting electrocardiogram, ST-segment deviation≥0.05mv and/or T-wave inversion≥0.2mv in the leads R-wave is predominant during non-attack period, or ST-segment deviation≥0.1mv and/or T-wave inversion≥0.2mv in the leads R-wave is predominant during angina attack; * Total exercise time of treadmill exercise test≥3 minutes.The discontinuance standard should be reached. And the difference of total exercise time between before and after run in period should ≤15%; * Other confirmed diagnostic evidence of coronary heart disease, such as definite history of old myocardial infarction, or incomplete revascularization one year after coronary intervention therapy(residual luminal stenosis≥50%), or coronary angiography evidence(at least single vessel disease and luminal stenosis≥50%), or nuclein examination evidence, or computer tomography angiography evidence; * Signed the informed consent form.

Exclusion criteria

* Chest pain caused by acute myocardial infarction(AMI), Class IV/serious angina pectoris, psychosis, serious neurosis, climacteric syndrome, hyperthyroidism, Cervical Spondylosis, gallbladder- heart syndrome, gastroesophageal reflux, hiatus hernia, aortic dissection, aortic valve disease; * Not well controlled hypertension(systolic pressure≥160mmHg,diastolic pressure≥100mmHg), serious cardiopulmonary insufficiency, serious arrhythmia(rapid atrial fibrillation, atrial flutter, paroxysmal ventricular tachycardia, etc); * Serious diseases of heart, lung, liver, kidney and blood; * Allergic constitution or allergic to the components of total Flavonoids of Propolis dropping pill; * Women during pregnancy or lactation; * Received any major operation within 4 weeks; * Have been in other clinical trials within 30 days; * Using but can not withdraw anti-angina medicine as long acting nitrates; * Not well controlled hyperglycemia; * Not fit for this trial judged by investigator.

Design outcomes

Primary

MeasureTime frame
Improvement of total exercise time of treadmill exercise test-2 week, 0 weeks, 12 weeks

Secondary

MeasureTime frameDescription
The marked effective rate of angina pectoris-2 weeks, 0 week, 6 weeks, 12 weeks* Class I: No symptom or almost no symptom, decrease of angina pectoris total score ≥ 1/3; * Class II: No symptom or almost no symptom, decrease of angina pectoris total score ≥ 2/3; * Class III: Almost no symptom, decrease of angina pectoris total score ≥ 2/3, or the score decrease to the degree of Slight or Class I.
Attack times of angina pectoris-2 weeks, 0 week, 6 weeks, 12 weeks
Pain degree of angina pectoris-2 weeks, 0 week, 12 weeks
Duration of angina pectoris attack-2 weeks, 0 week, 6 weeks, 12 weeks
Score change of the Seattle Angina Questionnaire (SAQ)0 week, 12 weeks
The main symptoms of Chinese Traditional Medicine-2 weeks, 0 week, 6 weeks, 12 weeksEffect index = (total score before treatment - total score after treatment)/total score before treatment×100% * Cured: effect index ≥90%; * Marked effective: 90%\> effect index ≥70%; * Effective: 70%\> effect index ≥30%; * Ineffective: effect index \<30%.
Improvement of ECG-2 weeks, 0 week, 12 weeks* Cured: normal or almost normal; * Marked effective: ST-segment deviation upturn≥0.05mV, but still abnormal, improvement of T-wave inversion of main leads ≥25%, or flate T-wave change to vertical, improved atrioventricular block or intraventricular block; * Effective: almost no charge; * Ineffective: anabatic ST-segment deviation, deeper T-wave, or flate T-wave change to inverted.
Improvement of other indexes of treadmill exercise test-2 weeks, 0 week, 12 weeksmetabolic equivalent, blood pressure, oxygen consumption, speed, grade.
Time to ST-segment deviation>1mm and positive symptoms appear-2 weeks, 0 week, 12 weeks
Dose change of nitroglycerin-2 weeks, 0 week, 6 weeks, 12 weeks* Withdraw: completely withdrawal after the treatment; * Decrease: decrement ≥50% after the treatment; * No change: decrement \<50% after the treatment.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026